首頁 > 市場調查報告書 > 製藥

醫藥品原料藥

市場調查報告書

商品編碼

1424471

高活性療效原料藥（HPAPI）市場：依分子類型、依生產技術、依應用、按地區

High Potency Active Pharmaceutical Ingredients Market, By Molecule Type, By Production Technology, By Application, By Geography

出版日期: 2024年01月19日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

高活性療效原料藥（HPAPI）的全球市場規模預計將從2023年的 278 億美元增至2030年的 549.9 億美元，預測期內年複合成長率為 10.2%。

報告範圍		報告詳情
基準年	2022年	2023/2024年市場規模	278億美元
實際資料	2018-2021	預測期	2023-2030
預測期間2023/2024 至2030/2031年年複合成長率：	10.20%	2030/2031價值預測	549.9億美元

圖 1.2023年高活性藥物成分的全球市場佔有率（依地區分類）

全球高活性療效原料藥（HPAPI）市場由專門生產高活性藥品的製藥業的重要部分組成。這些成分的特點是能夠在低濃度下發揮治療作用，並且能夠精確靶向特定的疾病細胞。由於其功效和作用高活性療效原料藥（HPAPI）擴大用於治療慢性和複雜的健康狀況，例如癌症、糖尿病和自體免疫疾病。隨著這些疾病在全球的盛行率持續上升，對高活性藥物的需求也在增加，推動全球高活性療效原料藥（HPAPI）市場向前發展。該領域的製造商大力投資研發（R&D），以開發具有更高安全性和功效的新型 HPAPI。這個市場受到嚴格監管，需要嚴格的遏制措施和專門的設施來處理這些強效物質，這些物質在一定程度的暴露下可能有毒，導致營運成為一個主要問題。此外，藥物技術的進步和創新促進了抗體藥物偶聯物（ADC）等標靶治療方法的發展，具有高度藥理活性的活性藥物成分（HPAPI）與單株抗體相結合，將活性化合物直接遞送至癌細胞。這種精確度透過減少對健康細胞的損害並最大限度地減少副作用來改善患者的治療結果。全球高活性療效原料藥（HPAPI）市場是一個充滿活力且不斷發展的領域，在有效管理複雜病理具有巨大潛力。隨著持續的開發投資、強力的法律規範以及個人化醫療的進步，HPAPI 在醫療保健領域的作用預計在不久的將來將顯著擴大。

市場動態：

全球高活性療效原料藥（HPAPI）市場的成長是由對生技藥品和標靶治療的需求不斷成長所推動的。癌症等慢性疾病的盛行率不斷上升，推動了對具有更高效力和特異性的生技藥品的需求。對罕見疾病孤兒藥開發的日益關注推動測試活動。預計這將對全球高活性療效原料藥（HPAPI）市場產生正面影響。

本研究的主要特點

本報告對全球高活性療效原料藥（HPAPI）市場進行了詳細分析，並列出了以2023年為基準年的預測期（2023-2030年）的市場規模和年複合成長率。
它確定了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球高活性療效原料藥（HPAPI）市場的主要企業。
本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球高活性療效原料藥（HPAPI）市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球高活性療效原料藥（HPAPI）市場的各種策略矩陣，將有助於相關人員做出決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
中部非洲
北非

第9章競爭形勢

公司簡介
- Lonza
- Novartis International AG
- BASF AG
- SEQENS
- Carbogen Amcis AG
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd
- Bristol-Myers Squibb
- Pfizer Inc.
- Roche Diagnostics
- Boehringer Ingelheim
- Merck &Co
- Bayer AG
- Ajinomoto Bio-Pharma Services
- Cambrex Corporation
- Minakem
- Sanofi Aventis

第10章

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI1336

Global high potency active pharmaceutical ingredients market size is expected to reach US$ 54.99 Bn by 2030, from US$ 27.80 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 10.2% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 27.80 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	10.20%	2030/2031 Value Projection:	US$ 54.99 Bn

Figure 1. Global High Potency Active Pharmaceutical Ingredients Market Share (%), By Region, 2023

High Potency Active Pharmaceutical Ingredients Market - IMG1

Global high potency active pharmaceutical ingredients (HPAPI) market comprises of a significant segment of the pharmaceutical industry that specializes in the production of highly potent drugs. These ingredients are characterized by their ability to deliver therapeutic effects at low concentrations and their potential to target specific disease cells with precision. High potency active pharmaceutical ingredients (HPAPIs) are increasingly utilized in the treatment of chronic and complicated health conditions such as cancer, diabetes, and autoimmune diseases due to their effectiveness and specificity in action. As the prevalence of these diseases continues to rise globally, so does the demand for high potency medication, propelling the global high potency active pharmaceutical ingredients (HPAPI) market forward. Manufacturers in this sector are investing heavily in research and development (R&D) to create new HPAPIs that offer improved safety and efficacy profiles. The highly regulated nature of this market necessitates stringent containment measures and specialized facilities to handle these potent substances, which can be toxic at certain levels of exposure, thereby presenting significant operational challenges. Moreover, the advancement in technology and innovation in pharmaceuticals is leading to the development of targeted therapy approaches like antibody-drug conjugates (ADCs), where high potency active pharmaceutical ingredients (HPAPIs) are conjugated with monoclonal antibodies to deliver the active compound directly to cancer cells. This precision reduces damage to healthy cells and minimizes side effects, thereby enhancing patient outcomes. Global high potency active pharmaceutical ingredients (HPAPI) market is a dynamic and evolving field that holds substantial promise for the effective management of complex medical conditions. With continued investment in development, strong regulatory frameworks, and the advancement of personalized medicine, its role in the healthcare sector is expected to expand significantly in the near future.

Market Dynamics:

The growth of the global high potency active pharmaceutical ingredients market is driven by the increasing demand for biologics and targeted therapies. Rising prevalence of chronic diseases like cancer is propelling the demand for biologics with higher potency and specificity. Growing focus on the development of orphan drugs for rare medical conditions is boosting trial activities. This is expected to positively impact the global high potency active pharmaceutical ingredients (HPAPI) market.

Key Features of the Study:

This report provides an in-depth analysis of the global high potency active pharmaceutical ingredients market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global high potency active pharmaceutical ingredients market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Lonza, Novartis International AG, BASF AG, SEQENS, Carbogen Amcis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb, Pfizer Inc., Roche Diagnostics, Boehringer Ingelheim, Merck & Co, Bayer AG, Ajinomoto Bio-Pharma Services, Cambrex Corporation, Minakem, and Sanofi Aventis
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics
Global high potency active pharmaceutical ingredients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global high potency active pharmaceutical ingredients market

Detailed Segmentation:

Global High Potency Active Pharmaceutical Ingredients Market, By Molecule Type
- Innovative
- Generic
Global High Potency Active Pharmaceutical Ingredients Market, By Production Technology
- Chemical Synthesis
- Biotechnology
Global High Potency Active Pharmaceutical Ingredients Market, By Application
- Oncology
- Hormonal
- Glaucoma
- Others
Global High Potency Active Pharmaceutical Ingredients Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in the Global High Potency Active Pharmaceutical Ingredients Market
- Lonza
- Novartis International AG
- BASF AG
- SEQENS
- Carbogen Amcis AG
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd
- Bristol-Myers Squibb
- Pfizer Inc.
- Roche Diagnostics
- Boehringer Ingelheim
- Merck & Co
- Bayer AG
- Ajinomoto Bio-Pharma Services
- Cambrex Corporation
- Minakem
- Sanofi Aventis

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market High Potency Active Pharmaceutical Ingredients, By Molecule Type
- Market High Potency Active Pharmaceutical Ingredients, By Production Technology
- Market High Potency Active Pharmaceutical Ingredients, By Application
- Market High Potency Active Pharmaceutical Ingredients, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising prevalence of cancer and other chronic diseases
- Restraints
High cost of production
- Opportunities
Increased production of specialty drugs
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global High Potency Active Pharmaceutical Ingredients Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global High Potency Active Pharmaceutical Ingredients Market, By Molecule Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Innovative
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global High Potency Active Pharmaceutical Ingredients Market, By Production Technology, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Chemical Synthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global High Potency Active Pharmaceutical Ingredients Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Hormonal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global High Potency Active Pharmaceutical Ingredients Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 - 2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
South Africa
Central Africa
North Africa

9. Competitive Landscape

Company Profile
- Lonza
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Novartis International AG
- BASF AG
- SEQENS
- Carbogen Amcis AG
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd
- Bristol-Myers Squibb
- Pfizer Inc.
- Roche Diagnostics
- Boehringer Ingelheim
- Merck & Co
- Bayer AG
- Ajinomoto Bio-Pharma Services
- Cambrex Corporation
- Minakem
- Sanofi Aventis
Analyst Views